Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jeffrey Feinblatt

Orthopaedic Surgery Oregon City, OR Medical Doctor

NPI 1982768834 CMS profile 391066

1508 Division St Ste 105, Oregon City, OR 97045

Open in the dashboard

General payments

$36,716

122 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jeffrey Feinblatt of Oregon City, OR is reported in the CMS Open Payments database as having received $36,716 across 122 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,481 13
2024 General $4,307 6
2023 General $5,561 31
2022 General $6,578 15
2021 General $5,580 14
2020 General $5,948 20
2019 General $5,261 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeffrey Feinblatt
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Jeffrey Feinblatt were reported at $3,481. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Jeffrey Feinblatt Orthopaedic Surgery median Middle half National median
2019 $5,261 $644 $140–$2,844 $163
2020 $5,948 $312 $75–$1,860 $114
2021 $5,580 $520 $117–$2,495 $132
2022 $6,578 $598 $128–$2,731 $149
2023 $5,561 $461 $128–$2,264 $160
2024 $4,307 $497 $134–$2,475 $164
2025 $3,481 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Acumed LLC $14,654 33 payments
  2. Novastep Inc. $5,784 4 payments
  3. Steelhead Surgical Inc $4,854 11 payments
  4. CurvaFix, Inc. $4,217 1 payment
  5. KCI USA, Inc $2,024 5 payments
  6. Miach Orthopaedics, Inc. $1,191 3 payments
  7. Stryker Corporation $1,048 11 payments
  8. GLW, Inc $858 1 payment
  9. Arthrex, Inc. $719 14 payments
  10. bioMerieux $300 1 payment
  11. Other $1,067 38 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $22,390 32 payments
  2. Travel and Lodging $4,460 9 payments
  3. Honoraria $4,217 1 payment
  4. Food and Beverage $3,652 78 payments
  5. Education $1,997 2 payments
Products named General payments · program years 2019–2025
  1. CENTROLOCK MIS Bunion Correction $5,600 2 payments
  2. CurvaFix IM Implant $4,217 1 payment
  3. Cannulated Screw System $3,059 6 payments
  4. ACUMED $2,602 6 payments
  5. PREVENA $2,010 2 payments
  6. Acutrak Headless Compression Screw System $1,531 1 payment
  7. Ankle Plating System Foot & Ankle $991 1 payment
  8. Ankle Plating System Foot & Ankle $963 1 payment
  9. Forefoot/Midfoot Plating System $963 1 payment
  10. PROSTEP $674 3 payments
  11. Other $3,117 71 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 108 billing codes

Paid by Medicare

$93,590

Of which drugs: $13,635

Medicare patients

307

Average age 73

Services billed

6,477

194 women, 113 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 68%
High blood pressure 60%
Depression 21%
Diabetes 18%
Ischemic heart disease 15%
Atrial fibrillation 15%
Osteoporosis 15%
Cancer 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg J7325 Office 17 1,296 $8,659
Injection, methylprednisolone acetate, 1 mg J1010 Office 44 3,401 $328

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

122 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record